In order to characterize the effects of VCP inhibition by CB-5083 on the ubiquitin-modified proteome of AML cells and to uncover its substrates, we employed quantitative mass spectrometry-based proteomics. This evidence concerns the gene VCP and acute myeloid leukemia.